オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

pharmaxis ltd - mannitol -

シンガポール - 英語 - HSA (Health Sciences Authority)

zuellig pharma pte. ltd. - mannitol (10mg capsule) - powder - 10 mg

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

btc speciality health pty ltd - mannitol, quantity: 0 mg - capsule, hard - excipient ingredients: gelatin - aridol is indicated for identifying bronchial hyperresponsiveness to assist in the diagnosis of asthma.

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

b & s healthcare - zafirlukast - film coated tablet - 20 milligram

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

pharmaxis europe limited - mannitol - inhalation powder, hard capsule - 0/5 mg/10 mg/20mg/40 milligram(s) - other diagnostic agents

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

remedyrepack inc. - fluticasone propionate (unii: o2gmz0lf5w) (fluticasone - unii:cut2w21n7u) - fluticasone propionate 220 ug - flovent hfa is indicated for the maintenance treatment of asthma as prophylactic therapy in patients aged 4 years and older. important limitation of use flovent hfa is not indicated for the relief of acute bronchospasm. the use of flovent hfa is contraindicated in the following conditions: - primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required [see warnings and precautions (5.2)] . - hypersensitivity to any of the ingredients [see warnings and precautions (5.6), adverse reactions (6.2), description (11)] . risk summary there are insufficient data on the use of flovent hfa in pregnant women. there are clinical considerations with the use of flovent hfa in pregnant women. (see clinical considerations.) in animals, teratogenicity characteristic of corticosteroids, decreased fetal body weight, and/or skeletal variations in rats, mice, and rabbits were observed with subcutaneously administered maternal toxic doses of fluticasone propionate less than the m

マレーシア - 英語 - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

astrazeneca sdn. bhd. - budesonide -

マレーシア - 英語 - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

astrazeneca sdn. bhd. - budesonide -